Fact CheckerSign in

NCT04137133Recruiting

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine.Descriptive Monocentric Study for Identification and Validation of Biomarkers Predictive of Clinical Evolution

Source: ClinicalTrials.gov · Last updated 23 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
22 Oct 2019
Start date
Mar 2022
Primary completion date
Mar 2030
Lead sponsor
University Hospital, Brest
NCT number
NCT04137133

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From Mar 2022 to the primary completion date, Mar 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Children colonized with P. aeruginosa according to the cytobacteriological examination and / or molecular test of sputum or pharyngeal specimens
  • Children grafted
  • Children not affiliated to a social security scheme or not entitled to
  • Children whose parent (s) are (are) minor (s)
  • Children whose holders of parental authority do not master the French language
  • Refusal to participate in the study

Who the study is looking for

  • Newly screened infants with a confirmed diagnosis of cystic fibrosis in its classic form (clinical symptoms and two positive sweat tests and/or two mutations of the cftr gene from Class I to III)
  • Children free of any colonization with P. aeruginosa
  • Affiliation with the social security system
  • Consent signed by the holders of parental authority or the sole parent holding parental authority

Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondation ILDYS
Coordinator of this site? Confirm its status
RoscoffFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.